Correction. In the article "Synthetic human seminal ainhibin-92 selectively suppresses follicle-stimulating hormone release in vivo" by Wen H. Yu, Samuel M. McCann, and Choh Hao Li, which appeared in number 1, January 1988, of Proc. Natl. Acad. Sci. USA (85,(289)(290)(291)(292), the authors request that the following change be noted. On page 292 in the next to the last paragraph of the paper, the sentence beginning on line 5 should read: "Furthermore, j3-IB-94-like activity has been found in extragonadal tissues such as the prostate (26). This polypeptide has no homology with a-IB-92, which has been found by radioimmunoassay in human serum, anterior pituitary, hypothalamus (29) Contributed by Choh Hao Li, September 8, 1987 ABSTRACT A 92-amino acid polypeptide, a-inhibin-92 (a-IB-92), has been isolated and characterized from human seminal plasma and found to be active in suppressing folliclestimulating hormone (FSH) release in vitro. In the present in vivo study, intravenous injection of synthetic a-IB-92 (4 and 20 jig) significantly suppressed FSH release (P < 0.001), whereas this peptide had no effect on luteinizing hormone (LH) release in 1-day orchidectomized male rats. In contrast, third ventricular injection of a-IB-92 (0.02, 0.4, 4, or 20 jig) had no effect on FSH and LH release in 1-or 2-day orchidectomized rats. These results indicate that ar-IB-92 exerts a FSH suppressing activity by direct action on the pituitary gland.
Inhibins are water-soluble gonadal peptides, which suppress the secretion of follicle-stimulating hormone (FSH) from the anterior pituitarygland (1) (2) (3) . FSH inhibiting substances have been detected in numerous gonadal tissues and fluids of mammals, such as rete testis fluid (4, 5) , seminal plasma (5) (6) (7) (8) , ovarian follicular fluid (9) (10) (11) (12) (13) (14) (15) , and media of cultured Sertoli (16, 17) and granulosa cells (18) . An inhibin-like peptide containing 31 amino acids (a-inhibin-31) was first synthesized and shown to be biologically active in vivo and in vitro (8, 19) . Recently, a 92-amino acid polypeptide, a-inhibin-92 (a-IB-92), has been isolated and characterized from human seminal plasma and found to be at least 40 times more active than a-inhibin-31 in suppressing FSH release in vitro (8) . In the present study, synthetic a-IB-92 (20) was injected i.v. and intracerebroventricularly (i.c.v.) into conscious orchidectomized rats to examine its biological activity to suppress FSH release in vivo. It was found that i.v. injection of this peptide inhibited FSH but not luteinizing hormone (LH) release in acutely castrated male rats. These results indicate that a-IB-92 exerts its action at the pituitary gland to suppress FSH release.
MATERIALS AND METHODS
Adult male rats (Sprague-Dawley, 250-300 g) were purchased from Holtzmann (Madison, WI). The animals were housed under controlled conditions of photoperiod (lights on, 0500-1900 hr) and temperature (23°C-25°C) with ad libitum access to food (Purina rat chow) and tap water. Synthetic a-IB-92 (20) was obtained in powder form. It was dissolved in 0.9% NaCl (saline) at the time of experimentation.
Experiment 1: i.v. Injection. Two days before blood sampling, silastic catheters (Dow Corning, Midland, MI) were inserted through the right external jugular vein into the right atrium to facilitate i.v. injection and blood withdrawal (21) . Male rats were bilaterally orchidectomized under light ether anesthesia 24 hr prior to the experiment and were caged individually thereafter. On the day of sampling, the rats were brought into a quiet room and polyethylene tubing (PE-50) was connected to the distal end of the jugular catheter. After acclimatization for 1 hr, an initial heparinized (100 units per 0.5 ml per rat) blood sample was withdrawn (0.5 ml) and a-IB-92 (0.4, 4, or 20 ,Ag in 1.0 ml of saline) or saline was injected i.v. into each rat. Blood samples (0.5 ml each) were obtained 1, 2, 3, 4, and 6 hr after i.v. injection. Blood volume was replaced by injection of 0.5 ml of warm (370C) heparinized saline (25 units/ml) after each sampling. Immediately after the 6-hr blood collection, a bolus of synthetic luteinizing hormone-releasing hormone (LHRH) (25 ng per 100 g body weight; Peninsula Laboratories, Belmont, CA) in 0. (23) . Animals were implanted withjugular-atrial catheters and castrated 2 days and 1 day before sampling. On the day of experimentation, after an initial blood sample (0.5 ml) was obtained, a stainless steel infusion cannula (30 gauge x 17 mm), which was connected to a microsyringe by polyethylene tubing (PE-10), was inserted into the third ventricular cannula. a-IB-92 (0.4 or 4 ,ug) or saline was microinjected into the third ventricle (i.c.v.) in a vol of 3 ,.d. Subsequent blood samples (0.5 ml each) were obtained 1, 2, 3, 4, and 6 hr after i.c.v. administration, and the same volume of heparinized saline was given to replace blood volume.
Since the baseline plasma FSH did not increase significantly in 1-day orchidectomized rats that were implanted with third ventricular cannulae, animals were used 2 days after orchidectomy in another experiment. Both a higher (20 ,ug) and lower (0.02 ,ug) dose of a-IB-92 were administered i.c.v. into these rats. Immediately after sampling, blood samples were centrifuged at 4°C, and plasma was stored at -20°C until assayed.
Radioimmunoassays. All plasma samples were measured in duplicate. LH was measured by the method of Niswender et al. (24) The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Statistics. Kruskal-Wallis nonparametric multiple comparisons were used to determine the levels of significance among the multiple groups at each time point.
RESULTS
The Effect of i.v. Injection of a-IB-92. Since plasma levels of FSH are rapidly elevated after castration, acutely orchidectomized male rats were used as assay animals to test the activity of a-IB-92 (2) . In the first experiment, the peptide A lowered plasma levels ofFSH 1 hr after i.v. injection at a dose of 4 1Lg. Values were significantly lowered for 1 hr and then returned toward the initial levels. FSH release was significantly suppressed within 1 hr and plasma FSH was still significantly lowered at the end of the experiment 6 hr after the 20-(pg dose (Fig. LA) . The lowest dose of0.4 ug of a-IB-92 was ineffective. On the other hand, plasma levels of LH were statistically unchanged after i.v. injection of a-IB-92 at all tested doses (Fig. 2) .
To injected i.v. 6 hr after injection of a-IB-92. The increment in plasma FSH after LHRH was increased in a dose-dependent manner by prior injection of a-IB-92 at doses of 4 and 20 ,ug (Fig. 1B) . However, the release of LH after i.v. injection of LHRH was not modified by any dose of a-IB-92.
The Effect of Intraventricular Injection of a-IB-92. To determine whether a-IB-92 exerted an action in the central nervous system to alter FSH release, this peptide was injected i.c.v. Intraventricular injection of a-IB-92 had no effect on both plasma FSH (Table 1) and LH (Table 2) in 1-day orchidectomized rats. The initial values of plasma FSH in males castrated for 1 day, which had already been implanted with ventricular cannulae several days earlier, were not significantly elevated compared to precastration values in these same animals. It was possible that the operation of ventricular cannulation delayed the rapid increase in plasma FSH, which occurred after orchidectomy in the previous experiment.
Consequently, a-IB-92 was injected i.c.v. in 2-day orchidectomized rats (Tables 3 and 4) . It failed to suppress Values are AFSH, ng/ml (mean + SEM). LHRH concentration was 25 ng per 100 g body weight. *Initial FSH = 771 + 39 ng/ml; n = 7.
tInitial FSH = 740 + 32 ng/ml; n = 5.
tInitial FSH = 692 + 28 ng/ml; n = 7.
hInitial FSH = 754 + 30 ng/ml; n = 5. $Changes with respect to initial concentrations.
I1Changes with respect to values at 8 hr.
FSH or LH release in these rats as well. Also, there was no difference in responsiveness of the pituitary gland to release FSH and LH after i.v. injection of LHRH in a-inhibin and saline-treated groups (Tables 3 and 4) .
DISCUSSION
The data presented here clearly indicate that a-IB-92 has a selective inhibitory action on the release of FSH from the pituitary gland of the castrate male rat in vivo. The molecule was earlier characterized and synthesized and showed high activity in vitro (8) . This is the first synthetic inhibin to show in vivo biological activity. In previous in vivo experiments (22) with i.v. injection of purified inhibin preparations, the responsiveness of the pituitary gland to LHRH has been impaired in terms of FSH Table 4 . i.c.v. injection of a-IB-92 had no effect on plasma LH release in 2-day orchidectomized rats IChanges with respect to initial concentrations.
lChanges with respect to values at 8 hr.
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release; however, our results contrasted with these earlier reports in that the responsiveness regarding FSH release was actually increased, and in a dose-related manner, when the testing with LHRH was performed 6 hours after injection of the inhibin preparation at a time when plasma FSH was still low. We speculate that this apparent enhanced responsiveness is due to the earlier reduction in release of FSH leading to accumulation of a readily releaseable pool of the hormone, which coupled to a removal of the inhibitory action of the inhibin at this time point some 6 hr after its injection led to increased responsiveness to LHRH. This would explain the fact that the enhancement of responsiveness was directly related to the degree of the previous inhibition of release. The responsiveness with regard to LH was not affected, presumably because there was no inhibition in its release in the hours prior to testing. The 31-amino acid inhibin-like peptide was previously reported to be active both in vivo and in vitro to inhibit FSH release (7, 19) ; however, in a recent report it was stated to lack activity (25) . These results could be due to the fact that only 30% ofthe synthetic preparation possessed the complete structure [for additional comments of Liu We had earlier found a suppressive action of partially purified inhibin injected intraventricularly on the release of FSH, which was not associated with an alteration in responsiveness of the pituitary gland to LHRH (22) . We did not find such an intrahypothalamic action of a-IB-92 in the present experiments. This could be related to the possibility that there is more than one kind of inhibin.
In this connection, several groups (11-15) have now isolated and determined the structure of a different molecule, which is a protein of two subunits (a and /3). a-IB-92 is a product of seminal plasma, whereas the other inhibin molecule is obtained from ovarian follicular fluid. Furthermore, a-IB-92-like activity has been found in extragonadal tissues such as the prostate (26) . Consequently, it is quite likely that there is more than one inhibin type molecule. The relative importance of the two activities remains to be determined.
There is no structural homology of a-IB-92 to the other type of inhibin (3) . That this other type may have physiologic significance is indicated by studies with antisera prepared against the initial amino acids of the a-subunit of this inhibin (27, 28) . These studies have shown that injection of these antisera can result in an increase in FSH, suggesting that that particular inhibin has physiological significance. It will be of great interest to carry out studies with antisera directed against a-IB-92 to determine its physiological significance.
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